Search research articles
Contact Us
Filters
Showing results (791-800 of 837) with videos related to
Page
of 84
Sort By:
Kidney International Reports
|
February 24, 2025
Kidney Disease: Improving Global Outcomes (KDIGO) Workshop on the Nurse's Role in Managing the Symptoms of People Receiving Dialysis
Paul Bennett, Madeleine Warren, Zehra Aydin, et al.
Nature
|
December 7, 2017
An 800-million-solar-mass black hole in a significantly neutral Universe at a redshift of 7.5
Eduardo Bañados, Bram P Venemans, Chiara Mazzucchelli, et al.
Biomaterials
|
June 21, 2024
In vitro and in vivo evaluation of biohybrid tissue-engineered vascular grafts with transformative <sup>1</sup>H/<sup>19</sup>F MRI traceable scaffolds
Elena Rama, Saurav Ranjan Mohapatra, Yukiharu Sugimura, et al.
Cancer Research
|
April 22, 2017
EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases
Aria Vaishnavi, Laura Schubert, Uwe Rix, et al.
Diabetologia
|
February 28, 2025
Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study
Dea H Kofod, Søren Z Diederichsen, Tobias Bomholt, et al.
The Medical Journal of Australia
|
October 15, 2023
Recommendations for culturally safe clinical kidney care for First Nations Australians: a guideline summary
David J Tunnicliffe, Samantha Bateman, Melissa Arnold-Chamney, et al.
Journal of Medicinal Chemistry
|
August 9, 2018
Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer
Johnny Nagasawa, Steven Govek, Mehmet Kahraman, et al.
Journal of Medicinal Chemistry
|
April 21, 2009
Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models
Céline Bonnefous, Joseph E Payne, Jeffrey Roppe, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927
Mehmet Kahraman, Steven P Govek, Johnny Y Nagasawa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 16, 2025
Multidrug micelles and sonopermeation for chemotherapy co-delivery to brain tumors
Anshuman Dasgupta, Jan-Niklas May, Geir Klinkenberg, et al.
Page
of 84
Search research articles
Search
Showing results (791-800 of 837) with videos related to
Sort By:
Page
of 84
Kidney International Reports
|
February 24, 2025
Kidney Disease: Improving Global Outcomes (KDIGO) Workshop on the Nurse's Role in Managing the Symptoms of People Receiving Dialysis
Paul Bennett, Madeleine Warren, Zehra Aydin, et al.
Nature
|
December 7, 2017
An 800-million-solar-mass black hole in a significantly neutral Universe at a redshift of 7.5
Eduardo Bañados, Bram P Venemans, Chiara Mazzucchelli, et al.
Biomaterials
|
June 21, 2024
In vitro and in vivo evaluation of biohybrid tissue-engineered vascular grafts with transformative <sup>1</sup>H/<sup>19</sup>F MRI traceable scaffolds
Elena Rama, Saurav Ranjan Mohapatra, Yukiharu Sugimura, et al.
Cancer Research
|
April 22, 2017
EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases
Aria Vaishnavi, Laura Schubert, Uwe Rix, et al.
Diabetologia
|
February 28, 2025
Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study
Dea H Kofod, Søren Z Diederichsen, Tobias Bomholt, et al.
The Medical Journal of Australia
|
October 15, 2023
Recommendations for culturally safe clinical kidney care for First Nations Australians: a guideline summary
David J Tunnicliffe, Samantha Bateman, Melissa Arnold-Chamney, et al.
Journal of Medicinal Chemistry
|
August 9, 2018
Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer
Johnny Nagasawa, Steven Govek, Mehmet Kahraman, et al.
Journal of Medicinal Chemistry
|
April 21, 2009
Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models
Céline Bonnefous, Joseph E Payne, Jeffrey Roppe, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927
Mehmet Kahraman, Steven P Govek, Johnny Y Nagasawa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 16, 2025
Multidrug micelles and sonopermeation for chemotherapy co-delivery to brain tumors
Anshuman Dasgupta, Jan-Niklas May, Geir Klinkenberg, et al.
Page
of 84